Stock market today: Wall Street gives back some gains after the Fed extends interest rate pause
Futures for the S&P 500 fell 0.4% before the bell and futures for the Dow Jones Industrial Average were down 0.3%. Nasdaq futures dipped 0.5%.
Discount retailer
Companies reporting after the closing bell Thursday include FedEx and
Also later Thursday, the
In addition to the Fed's announcement Wednesday, stocks were boosted by easing yields in the bond market. When Treasurys are paying investors less in interest, investors may be willing to pay higher prices for stocks.
The rally followed weeks of sharp swings for the
Fed Chair
Fed officials indicated they’re still penciling in two cuts to the federal funds rate by the end of this year.
Powell pushed back against fears about what’s called “ stagflation,” where the economy stagnates but inflation remains high.
In
Markets were closed in
In



Idaho governor signs bill to privatize management, add work requirements to Medicaid program
Tariffs will increase car parts, but also auto insurance costs
Advisor News
- Addressing the ‘menopause tax:’ A guide for advisors with female clients
- Alternative investments in 401(k)s: What advisors must know
- The modern advisor: Merging income, insurance, and investments
- Financial shocks, caregiving gaps and inflation pressures persist
- Americans unprepared for increased longevity
More Advisor NewsAnnuity News
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Aspida Life and WealthVest Offer a Powerful New Guaranteed Income Product with the WealthLock® Income Builder
- Lack of digital tools drives wedge between insurers, advisors
- LIMRA: Annuity sales notch 10th consecutive $100B+ quarter
- AIG to sell remaining shares in Corebridge Financial
More Annuity NewsHealth/Employee Benefits News
- Studies from Denise Wolff et al Have Provided New Data on Atopic Dermatitis (AMCP Market Insights: Beyond skin deep on the role of managed care in moderate to severe atopic dermatitis): Skin Diseases and Conditions – Atopic Dermatitis
- New Clinical Trials and Studies Findings from RAND Corporation Described (Benefit design and consumer information: results from a randomized trial): Clinical Research – Clinical Trials and Studies
- School, BOCES healthcare costs up 22%, here’s why
- Healthcare cuts threaten Sullivan's reelection chances in Alaska
- Health insurance marketplace feels growing tremors from GOP cuts
More Health/Employee Benefits NewsLife Insurance News
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Dan Scholz to receive NAIFA’s Terry Headley Lifetime Defender Award
- Best’s Special Report: US Property/Casualty and Health Insurers Exceed Cost of Capital; Life Insurers Narrowly Miss
- Aspida Life and WealthVest Offer a Powerful New Guaranteed Income Product with the WealthLock® Income Builder
- Lack of digital tools drives wedge between insurers, advisors
More Life Insurance News